Tech, you know that Moffitt is one of the Sunrise Trial Sites, right?
I posted this several months ago:
From the H. Lee Moffit Cancer Center website in Tampa:
moffitt.org/research--clinical-trials/clinical-trials/clinical-trial-17681
Clinical Trial 17681
Study Title
SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel versus Docetaxel Alone as Second-Line Therapy in Patients with Stage IIIb/IV Non-Squamous Non-Small-Cell Lung Cancer
Summary
The primary purpose of this research study is to see whether adding bavituximab to the standard chemotherapy drug docetaxel will improve the results of the treatment for non-small-cell lung cancer.